|
Match
|
Document |
Document Title |
|
|
7531500 |
Preventing airway mucus production by administration of EGF-R antagonists
Hypersecretion of mucus in the lungs is inhibited by the administration of an epidermal growth factor receptor (EGF-R) antagonist. The EGF-R antagonist may be in the form of a small organic...
|
|
|
7531498 |
Peroxycarboxylic acid-based bleach compositions having a long shelf life
A gel capsule, loaded with at least one organic percarboxylic acid is manufactured by the process comprising the steps of: (a) providing an oil having a melting point below 35° C. at atmospheric...
|
|
|
7527808 |
Amorphous cefditoren pivoxil composition and process for producing the same
An objective of the present invention is to provide an amorphous cefditoren pivoxil composition possessing excellent stability and dissolvability and to provide a production process of the...
|
|
|
7470435 |
Extended release venlafaxine formulation
A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.
|
|
|
7452552 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Pharmaceutical compositions for lipophilic drugs
Stable solutions of lipophilic drugs, such as cyclosporin, forming a polar lipid self-emulsifying drug delivery system. The solutions can include lipophilic drugs, such as cyclosporin, dissolved in...
|
|
|
7452551 |
Targeted compositions for diagnostic and therapeutic use
Novel targeted compositions which may be used for diagnostic and therapeutic use. The compositions may comprise lipid, protein or polymer gas-filled vesicles which further comprise novel compounds...
|
|
|
7445796 |
Pharmaceutically active particles of a monomodal particle size distribution and method
A method of obtaining improved reproducibility of dissolution profiles of dosage forms containing pharmaceutically active particles includes steps of screening raw pharmaceutically active particles...
|
|
|
7445616 |
Temperature responsive systems
A shape memory material activated device of the present invention uses a shape memory material activator to create a path through a shell wall of the device. The path through the shell wall may...
|
|
|
7417022 |
Compounds and compositions for delivering active agents
Modified amino acid compounds useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.
|
|
|
7341742 |
Simethicone containing tablet composition and method
A process and pharmaceutical composition containing simethicone and magnesium carbonate allows a higher production rate of simethicone containing tablets and a more consistent end product tablet....
|
|
|
7332182 |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
Disclosed in certain embodiments is an oral dosage form comprising:
a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and an irritant in an effective amount to...
|
|
|
7276252 |
Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form
A drug delivery device such as an oral dosage form (ODF) with a toxic or potent core encapsulated by a non-toxic region. The non-toxic region may be a region including multiple layers, coatings,...
|
|
|
7273623 |
Process for preparing tannate tablet, capsule or other solid dosage forms
An active pharmaceutical ingredient is combined with tannic acid to form a tannate salt complex of the active ingredient. The active ingredient tannate salt complex without isolation or...
|
|
|
7273622 |
Super absorption Coenzyme Q10
An improved soft gelatin formulation and process methodology that increases single Coenzyme Q 10 molecules presented to the absorption channels of the small intestines by providing medium chain...
|
|
|
7264824 |
Oral dosage form
Oral dosage form for food and food supplement as well as dietetics comprising polyunsaturated acids in a xylose-hardened gelatine capsule with a retarded release time.
|
|
|
7201921 |
Antihistamine formulations for soft capsule dosage forms
The invention herein relates to a pharmaceutical composition containing loratadine and derivatives thereof which is suitable for use in soft capsule dosage forms. A pharmaceutical composition...
|
|
|
7195778 |
Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
The invention is directed to a drug delivery device for controlled release of a drug, comprising a core that has a cylindrical plug embedded therein; and a coating that at least partially surrounds...
|
|
|
7195777 |
Method and apparatus for blowmoding capsules of polyvinylalcohol and blowmolded polyvinylalcohol capsules
A capsule is formed from a PVA composition by blow moulding. Such capsules can at last provide a viable alternative to gelatin for bio-degradeable capsule containing a pharmaceutical or consumable...
|
|
|
7186293 |
Agglomerated starch compositions
Agglomerated starch compositions containing native starch and pre-compacted starch powder is disclosed. The agglomerated starch compositions have superior flow and less pH sensitivity than simple...
|
|
|
7182958 |
β-carboline pharmaceutical compositions
Formulations containing a PDE5 inhibitor, a water-soluble diluent, a lubricant, a hydrophilic binder, a disintegrant, and optional microcrystalline cellulose and/or a wetting agent, and their use...
|
|
|
7179791 |
Inhibiting GS-FDH to modulate NO bioactivity
Patients needing NO donor therapy or inhibition of pathologically proliferating cells or increased NO bioactivity are treated with a therapeutically effective amount of an inhibitor of...
|
|
|
7163693 |
Multi-component pharmaceutical dosage form
A multi-component pharmaceutical dosage form comprising a plurality of drug substance-containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer...
|
|
|
7157102 |
Multi-layered microcapsules and method of preparing same
A multi-layered microcapsule containing one or more active ingredients and process for preparing the same is disclosed. The multi-layered microcapsule comprises an inner solid microparticle core,...
|
|
|
7147867 |
Dosage form comprising liquid formulation
A dosage form is disclosed comprising a drug formulation that self-emulsifies in the drug formulation.
|
|
|
7144585 |
Cilostazol preparation
Provided is a cilostazol preparation which comprises incorporating a fine powder of cilostazol into a dispersing and/or solubilizing agent thereby to enhance the dispersibility and/or solubility....
|
|
|
7122207 |
High drug load acid labile pharmaceutical composition
A high drug load spheronized beadlet is provided wherein said beadlet comprises about 80% to 100% by weight of an acid labile medicament, preferably didanosine, about 0% to about 10% by weight of a...
|
|
|
7118762 |
Controlled release lipoic acid
A controlled release formulation of lipoic acid is disclosed. The lipoic acid is combined with excipient materials in such a way that those materials provide for gradual release of the lipoic acid...
|
|
|
7115281 |
Processes for the preparation of oral dosage formulations of modafinil
The invention relates to processes for preparing, and pharmaceutical compositions of, modafinil dosage forms for oral administration. The dosage forms include a mixture of coarse and fine particles...
|
|
|
7115277 |
Method for enabling delivery of an active agent
A method for enabling deliver of an active agent is provided which includes the preparation of doses of the active agent distributing educational materials and guidelines for counseling patients...
|
|
|
7108866 |
Chronotherapeutic diltiazem formulations and the administration thereof
A controlled-release Galenical preparation of pharmaceutically acceptable Diltiazem including the pharmaceutically acceptable salts thereof, suitable for evening dosing every 24 hours containing...
|
|
|
7083808 |
Controlled/modified release oral methylphenidate formulations
The invention is directed to oral modified/controlled release methylphenidate formulations which provide a rapid initial onset of effect and a prolonged duration of effect. Preferably, the peak...
|
|
|
7078054 |
Soft gelatin capsule manufacture
Soft gelatin capsules having a capsule shell comprising gelatin, plasticizers and, if desired or required, further auxiliary agents, and a capsule filling containing a solvent including a...
|
|
|
7074390 |
Encapsulated dentifrice and method of use
A single use capsule containing dentifrice is disclosed. It includes toothpaste or other dentifrice enclosed in a shell or coating. The dentifrice may include miswak fibers, which acts as a natural...
|
|
|
7070817 |
Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases
The invention relates to an herbal composition comprising extract of plant Moringa Oleifera , a member of family Moringaceae, plant Piper Nigrum , a member of family Piperaceae and plant ...
|
|
|
7070802 |
Pharmaceutical compositions for lipophilic drugs
Stable solutions of lipophilic drugs, such as cyclosporin, forming a polar lipid self-emulsifying drug delivery system. The solutions can include lipophilic drugs, such as cyclosporin, dissolved in...
|
|
|
7041319 |
Fenofibrate pharmaceutical composition having high bioavailabilty
The invention provides fenofibrate tablets comprising granulates, wherein the granulates can comprise carrier particles, micronized fenofibrate, and at least one hydrophilic polymer.
|
|
|
7041315 |
Pectin film compositions
The invention concerns, film-forming compositions containing pectin, at least one additional film-forming polymer and a setting system for use in pharmaceutical, veterinary, food, cosmetic or other...
|
|
|
RE39079 |
Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
Disclosed herein are compositions comprising a modified starch and a carrageenan, especially iota-carrageenan, where the compositions are suitable for use in manufacturing soft capsules.
|
|
|
7022663 |
Oral, nasal and pulmonary dosage formulations of copolymer 1
Pharmaceutical compositions useful for treating autoimmune diseases in a mammal comprising as an active ingredient a therapeutically effective amount of Copolymer 1, and microcrystalline cellulose...
|
|
|
7022337 |
Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect
A fibrate self-emulsifying oral formulation with improved bioavailability when compared to commercially available formulations containing a therapeutically effective dose of fenofibrate, derivative...
|
|
|
7019106 |
Lactic acid polymer and process for producing the same
A process for producing a lactic acid polymer of 15,000 to 50,000 in weight-average molecular weight, the content of polymeric materials having not more than about 5,000 in weight-average molecular...
|
|
|
7011846 |
Oral capsule formulation with increased physical stability
A formulation for a stabilized capsule for oral administration of a hydrophobic pharmaceutically active agent; comprising a non-aqueous solubilizer selected from 2-pyrrolidone, N-alkylpyrrolidones...
|
|
|
7011818 |
Carrier particles for use in dry powder inhalers
A powder for use in a dry powder inhaler includes active particles and carrier particles for carrying the active particles. The powder further includes additive material ( 4 ) on the surfaces of...
|
|
|
7008640 |
Pharmaceutical composition for oral use with improved absorption
The present invention presents a pharmaceutical composition for oral use with improved absorption, which comprises drug, aminoalkyl methacrylate copolymer E, and acidic substance and is obtained by...
|
|
|
6991807 |
Antibiotic composition
Disclosed are antibiotic products for delivering at least two different antibiotics, wherein the products are comprised of at least three or four dosage forms with different release profiles and...
|
|
|
6989150 |
Cosmetic preparation of active substances with a synergistically increased radical protection factor
The inventive cosmetic preparation of active substances, as such as well as in combination with other active substances, protects the skin against free radical aggression in a particularly...
|
|
|
6984399 |
Solid pharmaceutical formulation containing lovastatin and simvastatin respectively, and its preparation
The present invention relates to a novel solid pharmaceutical formulation containing lovastatin and simvastatin, respectively, with a particle size D(0.9) between 15 and 100 μm and a specific...
|
|
|
6979462 |
Stabilization of solid drug formulations
Pharmaceutical formulations and dosage forms are provided having improved stability to moisture-induced degradation when compared with conventional dosage forms, especially tablets. The invention...
|
|
|
6960356 |
Orally administered drug delivery system providing temporal and spatial control
A pharmaceutical composition in the form of tablets or capsules provides a combination of temporal and spatial control of drug delivery to a patient for effective therapeutic results. The...
|
|
|
6955821 |
Sustained release formulations of guaifenesin and additional drug ingredients
The invention relates to a novel pharmaceutical sustained release formulation of guaifenesin and at least one additional drug ingredient. The formulation may comprise a hydrophilic polymer,...
|